In a lawsuit, the FTC accused Optum Rx, Caremark and Express Scripts of creating "a broken rebate system that inflated ...

The Federal Trade Commission is suing the three largest prescription drug benefit managers (PBMs) for allegedly driving up ...

Insulin can be a critical part of managing diabetes, but patients may not know all the ins and outs of using the medication effectively. Luckily, the American Diabetes Association (ADA) has plenty ...

The U.S. Food and Drug Administration on Monday approved the expanded use of an automated insulin pump system to include those with type 2 diabetes. It's the first such system for use by people ...

Aug. 26 (UPI) --The Food and Drug Administration on Monday approved Insulet's Omnipod 5 automated insulin delivery system for people with Type 2 diabetes. In 2022, the FDA signed off on the system ...

The FDA has cleared its first automated insulin pump for adults with Type 2 diabetes, with Insulet’s Omnipod 5 delivery system opening the door to a population of more than 6 million people.

People with type 1 diabetes must monitor their blood glucose levels and inject precise doses of insulin several times a day to avoid health complications. Now, diabetes researchers are developing ...

Many of those living with diabetes need insulin to survive, but the price of the medication in the United States is often expensive. That’s why the federal government and several drug companies ...

Friday initiated legal action against the three largest prescription drug benefit managers (PBMs) in the U.S.—Caremark Rx, ...

The losers in this dysfunctional market are drug makers and patients. The lawsuits generally make two claims: that insulin prices are unreasonably high and that drug companies and PBMs are ...